Article Text

Download PDFPDF

P58 Advance care planning in glioblastoma patients: development of a disease-specific ACP program
  1. L Fritz1,
  2. H Zwinkels1,
  3. J Koekkoek1,2,
  4. J Reijneveld3,4,
  5. M Vos1,
  6. L Dirven1,2,
  7. R Pasman5 and
  8. M Taphoorn1,2
  1. 1Haaglanden Medical Center, The Hague, Netherlands
  2. 2Leiden University Medical Center, Leiden, Netherlands
  3. 3Amsterdam University Medical Centers (location VUmc), Amsterdam, Netherlands
  4. 4Amsterdam University Medical Centers (location Academic Medical Center), Amsterdam, Netherlands
  5. 5Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam Public Health research institute, Expertise center for Palliative care Amsterdam, Amsterdam, Netherlands


Background It is unknown if implementation of an Advance Care Planning (ACP) program is feasible in daily clinical practice for glioblastoma patients. We aimed to develop an ACP program, and assessed the preferred content, the best time to introduce such a program in the disease trajectory, and possible barriers and facilitators for participation and implementation.

Methods A focus group with health care professionals (HCPs) as well as individual semi-structured interviews with patients and proxies (of both living and deceased patients) were conducted.

Results All predefined topics were considered relevant by participants, including the current situation, worries and fears, (supportive) treatment options, and preferred place of care/death. Although HCPs and proxies of deceased patients indicated that the program should be implemented relatively early in the disease trajectory, patient-proxy dyads were more ambiguous. Several patient-proxy dyads indicated that the program should be initiated later in the disease trajectory. If introduced early, topics about the end-of-life should be postponed. A frequently mentioned barrier for participation was that the program would be confronting, while a facilitator included access to information.

Conclusion This study resulted in an ACP program specifically for glioblastoma patients. Although participants agreed on the content of the program, the optimal timing of introducing such a program was a matter of debate. Our solution is to offer the program shortly after diagnosis, but let patients and proxies decide which topics they want to discuss. The impact of the program on several patient- and care-related outcomes will be evaluated in a next step.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.